S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Hvivo (HVO) Share Forecast, Price & News

GBX 16.50
-0.88 (-5.04%)
(As of 01/17/2020)
Today's Range
50-Day Range
52-Week Range
79,622 shs
Average Volume
142,465 shs
Market Capitalization
£13.80 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive HVO News and Ratings via Email

Sign-up to receive the latest news and ratings for Hvivo and its competitors with MarketBeat's FREE daily newsletter.

About Hvivo

hVIVO plc, a specialty biopharma company, provides medical and scientific research services in the United Kingdom, the United States, and Europe. The company is developing a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases, including influenza virus, respiratory syncytial virus, asthma exacerbation, and human rhinovirus. It also offers laboratory based research services; and target and biomarker discovery services. hVIVO plc primarily serves pharmaceutical and biotech customers. The company was formerly known as Retroscreen Virology Group plc and changed its name to hVIVO plc in April 2015. hVIVO plc was incorporated in 1988 and is based in London, the United Kingdom.


Open Orphan Share Chat
Hvivo Plc Share Chat
Hvivo Share News (HVO)
Can hVIVO (LON:HVO) Afford To Invest In Growth?
Successful RSV Challenge Study in Older Adults
Hvivo Share Chat (HVO)
RSV Challenge Model Delivers Positive Results
See More Headlines

Industry, Sector and Symbol

Year Founded

Sales & Book Value

Annual Sales
£12.09 million
Cash Flow
GBX 4.90 per share
Book Value
GBX 16.50 per share


Pretax Margin




Free Float
Market Cap
£13.80 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Hvivo (LON:HVO) Frequently Asked Questions

How were Hvivo's earnings last quarter?

Hvivo PLC (LON:HVO) posted its earnings results on Thursday, April, 19th. The company reported ($16.50) EPS for the quarter, missing analysts' consensus estimates of ($10.90) by $5.60.
View Hvivo's earnings history

Who are Hvivo's key executives?
Hvivo's management team includes the following people:
  • Mr. Graham Edward Yeatman, Chief Financial & Bus. Officer and Company Sec. (Age 52)
  • Mr. David Robert Norwood, Strategic Consultant (Age 50)
  • Dr. Trevor Michael Phillips, Exec. Chairman & CEO (Age 58)
  • Ms. Fleur Wood, Exec. VP of Investor Relations & Communications
  • Colin Paterson, Director of Marketing, Communication & PR
What other stocks do shareholders of Hvivo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hvivo investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY).

What is Hvivo's stock symbol?

Hvivo trades on the London Stock Exchange (LON) under the ticker symbol "HVO."

How do I buy shares of Hvivo?

Shares of HVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Hvivo's stock price today?

One share of HVO stock can currently be purchased for approximately GBX 16.50.

How much money does Hvivo make?

Hvivo has a market capitalization of £13.80 million and generates £12.09 million in revenue each year.

What is Hvivo's official website?

The official website for Hvivo is hvivo.com.

How can I contact Hvivo?

Hvivo's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The company can be reached via phone at +44-20-77561300.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.